Literature DB >> 6705881

Correlation between electrocorticographic and motor phenomena induced by pentamethylenetetrazol during ontogenesis in rats.

R Schickerová, P Mares, S Trojan.   

Abstract

Motor and electrocorticographic (ECoG) phenomena induced by pentamethylenetetrazol (PTZ) were directly compared in adult as well as in young rats (age groups of 7, 12, and 18 days). The technique for implantation of cortical electrodes was elaborated in young rats. Myoclonic jerks were elicited by PTZ in all age groups studied. In adult animals they were accompanied by isolated spikes and/or spike-and-wave complexes, whereas in 7-day-old rats there was a poor correlation between ECoG abnormalities and myoclonic jerks. With increasing age an improved correlation between ECoG abnormalities and behavioral changes were noted. After further injections of PTZ, rats had generalized tonic-clonic motor seizures. Ictal ECoG activity usually started in one cortical region in 7-day-old rats and became progressively generalized whereas in older rats generalized electrical discharges accompanied the motor seizures from onset. The clonic phase of motor seizures was not always accompanied by specific ECoG changes in young rats. At all ages the correlation between ECoG activity and individual phases of the generalized tonic-clonic seizures was poor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705881     DOI: 10.1016/0014-4886(84)90012-8

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  3 in total

1.  Febrile seizures: an appropriate-aged model suitable for long-term studies.

Authors:  T Z Baram; A Gerth; L Schultz
Journal:  Brain Res Dev Brain Res       Date:  1997-02-20

Review 2.  Febrile seizures and mechanisms of epileptogenesis: insights from an animal model.

Authors:  Roland A Bender; Celine Dubé; Tallie Z Baram
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

3.  Convulsant action of a benzodiazepine receptor agonist/inverse agonist Ro 19-4603 in developing rats.

Authors:  H Kubová; P Mares
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.